Methods and benefits of administration monitoring. Results obtained with flunisolid MDI in 3,742 patients with chronic obstructive airway diseases. (Record no. 1497270)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01130 a2200289 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250511185936.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199302s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0174-4879 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Köhler, M E |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19930226 |
| 245 00 - TITLE STATEMENT | |
| Title | Methods and benefits of administration monitoring. Results obtained with flunisolid MDI in 3,742 patients with chronic obstructive airway diseases. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | International journal of clinical pharmacology, therapy, and toxicology |
| Date of publication, distribution, etc. | Nov 1992 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 473 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anti-Inflammatory Agents |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Fluocinolone Acetonide |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Germany |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Diseases, Obstructive |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Nebulizers and Vaporizers |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Product Surveillance, Postmarketing |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Risk |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kemmer, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wolf, K |
| 773 0# - HOST ITEM ENTRY | |
| Title | International journal of clinical pharmacology, therapy, and toxicology |
| Related parts | vol. 30 |
| -- | no. 11 |
| -- | p. 473 |
No items available.